Dcp2: an mRNA decapping enzyme that adopts many different shapes and forms

Curr Opin Struct Biol. 2019 Dec:59:115-123. doi: 10.1016/j.sbi.2019.07.009. Epub 2019 Aug 29.

Abstract

Eukaryotic mRNAs contain a 5' cap structure that protects the transcript against rapid exonucleolytic degradation. The regulation of cellular mRNA levels therefore depends on a precise control of the mRNA decapping pathways. The major mRNA decapping enzyme in eukaryotic cells is Dcp2. It is regulated by interactions with several activators, including Dcp1, Edc1, and Edc3, as well as by an autoinhibition mechanism. The structural and mechanistical characterization of Dcp2 complexes has long been impeded by the high flexibility and dynamic nature of the enzyme. Here we review recent insights into the catalytically active conformation of the mRNA decapping complex, the mode of action of decapping activators and the large interactions network that Dcp2 is embedded in.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Binding Sites
  • Endoribonucleases / chemistry*
  • Endoribonucleases / metabolism*
  • Humans
  • Models, Molecular*
  • Molecular Conformation
  • Phase Transition
  • Protein Binding
  • Protein Interaction Maps
  • RNA Caps / chemistry
  • RNA, Messenger / chemistry
  • RNA, Messenger / genetics

Substances

  • RNA Caps
  • RNA, Messenger
  • mRNA decapping enzymes
  • Endoribonucleases
  • DCP2 protein, human